Boruikang Technology

About Boruikang Technology

Boruikang Technology (Neuracle) is a high-tech enterprise focused on brain-computer interface (BCI) systems. Founded in November 2011 by Dr. Xu Honglai and Dr. Huang Xiaoshan from Tsinghua University's neuro-engineering department, the company leverages its founders' deep expertise in BCI system design and neural signal processing. The core team originates from Tsinghua University's Neuroengineering Laboratory, a top-five global institution in brain-computer intelligence, supplemented by experts from the clinical neuro-field.

The company provides comprehensive solutions for neuroscience research and clinical applications, including the diagnosis, treatment, and rehabilitation of neurological diseases. Its client base includes renowned universities such as Tsinghua University and Peking University, as well as major hospitals like Xuanwu Hospital and Huashan Hospital. Boruikang generates revenue through the research, development, production, and sale of BCI-related equipment and providing technical services.

Boruikang has developed a product portfolio catering to both research and medical markets. For scientific research in fields like neuroscience and psychology, it offers research-grade EEG acquisition and stimulation equipment. For the medical sector, it provides medical-grade EEG devices for diagnosing and monitoring conditions such as epilepsy and cerebrovascular diseases. A key area of development is its micro-invasive BCI system, known as Neural Electronic Opportunity (NEO), created in collaboration with a team from Tsinghua University. This semi-invasive system involves implanting a coin-sized device into the skull but outside the brain cortex, aiming to balance high signal quality with reduced surgical risk compared to fully invasive methods. The NEO system has entered a special review process for innovative medical devices in China and is undergoing clinical trials for applications like treating refractory epilepsy and aiding in the rehabilitation of patients with spinal cord injuries.